ReNeuron Group Plc (RENE) rose the most in three months in London after the U.K. company released interim data from a study that showed its stem-cell therapy helped reduce impairment in nine stroke patients.

... Inc. -- Genable Technologies Limited -- Mimetogen Pharmaceuticals Inc. -- Neurotech Pharmaceuticals, Inc. -- QLT Inc. -- R-Tech Ueno, Ltd.

The stem cell trial started in 2010, with one stroke patient, an elderly Scotsman who was injected with ReN001 cells developed by ReNeuron Group plc, at the trial center at Southern General Hospital in Glasgow, UK. By 2012, there were six patients on ...